A snippet from the 2020 AGM, (Revisit the 2020 AGM Presentation for clarity) There is a lot to like
VALUE PROPOSITION:Manufacturer of regulatory cleared medical devices (SaMD)
5 Regulatory Cleared Services
Targeting FDA clearance on second AI solution, HepaFat-AI
DiverseR&DPipeline
Artificial Intelligence
Imaging
Molecular Medicine
Growing Revenue
Services being used in 9 active clinical trials
Increased revenue despite impact from COVID-19
4 channel partners for distribution of AI product
Strong Balance Sheet
Cash balance of $7.5m
Cash flow positive from the last 10 consecutive quarters
Company has no debt
A snippet from the 2020 AGM, (Revisit the 2020 AGM Presentation...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
